Cardiovascular Health Trajectories and Elevated C-Reactive Protein: The CARDIA Study

Jonathan J Ruiz-Ramie1,2, Jacob L Barber2, Donald M Lloyd-Jones3

  • 1Department of Kinesiology Augusta University Augusta GA.

Insights

Maintaining good cardiovascular health (CVH) from young adulthood is crucial. Poor or declining CVH trajectories are linked to higher C-reactive protein (CRP) levels in middle age, indicating increased inflammation.

Area of Science:

  • Cardiovascular Health
  • Inflammation Biomarkers
  • Longitudinal Studies

Background:

  • The link between long-term cardiovascular health (CVH) trajectories and elevated C-reactive protein (CRP) in middle age remains understudied.
  • Investigating this relationship is vital for understanding chronic inflammation development.
  • The Coronary Artery Risk Development in Young Adults (CARDIA) study provides a unique dataset for this analysis.

Purpose of the Study:

  • To examine the association between distinct long-term cardiovascular health (CVH) patterns from young adulthood to middle age and elevated C-reactive protein (CRP) levels.
  • To identify specific CVH trajectories associated with increased inflammation markers.
  • To analyze race-specific differences in these associations.

Main Methods:

  • Utilized data from 4405 Black and White participants in the CARDIA study over 25 years.
  • Employed latent class modeling to define CVH trajectories based on multiple health components.
  • Applied multivariable Poisson regression to assess the relationship between CVH trajectories and elevated CRP (>3.0 mg/L) prevalence.

Main Results:

  • Identified five distinct CVH trajectories for both Black and White participants.
  • Lower and decreasing CVH trajectories were significantly associated with a higher prevalence of elevated CRP at 25-year follow-up.
  • Individuals in the lowest CVH trajectory groups showed substantially higher odds of chronically elevated CRP compared to those with the highest CVH trajectory.

Conclusions:

  • Long-term cardiovascular health trajectories significantly impact C-reactive protein levels in middle age.
  • Declining or consistently poor CVH is a predictor of elevated inflammation.
  • These findings highlight the importance of sustained cardiovascular health throughout early and mid-adulthood for mitigating chronic inflammation.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
126
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
523
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
413
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
440
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75